Development and First Use of the Patient's Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit-Harm of Drugs Received During Clinical Studies.
Adam GaterMatthew ReaneyAmy FindleyCatherine Brun-StrangKate BurrowsMy-Liên Nguyên-PascalAude Roborel de ClimensPublished in: Drug safety (2020)
ClinicalTrials.gov identifier: NCT02973321.